Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prediction of migraine treatment response with clinical and genetic data: A machine learning analysis of the HUNT study.

Cephalalgia : an international journal of headache·2026
Same author

Cutting through stigma: psychiatry and neurosurgery working together.

The British journal of psychiatry : the journal of mental science·2026
Same author

DBS: from neuromodulation to neuroremodelling.

Nature neuroscience·2026
Same author

Unilateral promise and bilateral caution in focused ultrasound for Parkinson's disease.

The Lancet. Neurology·2026
Same author

Machine Diagnostics and Machine Phenotyping of Migraine: A HUNT Study.

Neurology·2026
Same author

A prognostic human brain network for diffuse midline glioma.

Nature·2026

Related Experiment Video

Updated: Mar 23, 2026

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain
09:35

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain

Published on: May 10, 2017

19.8K

Ventral tegmental area deep brain stimulation for refractory chronic cluster headache.

Harith Akram1, Sarah Miller2, Susie Lagrata2

  • 1From the Unit of Functional Neurosurgery (H.A., J.H., M.J., M.H., L.Z.), Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, University College London; Victor Horsley Department of Neurosurgery (H.A., J.H., L.Z.), National Hospital for Neurology and Neurosurgery, London; Headache Group (S.M., S.L., M.M.), Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, UK; and Department of Neurosurgery (M.H.), University Hospital, Umeå, Sweden. harith.akram.12@ucl.ac.uk.

Neurology
|April 1, 2016
PubMed
Summary

Ventral tegmental area deep brain stimulation (VTA-DBS) offers a safe and effective treatment for chronic cluster headache (CCH) patients. This therapy significantly reduces headache frequency, severity, and overall headache load.

More Related Videos

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.9K
Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
14:14

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Published on: August 12, 2018

9.4K

Related Experiment Videos

Last Updated: Mar 23, 2026

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain
09:35

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain

Published on: May 10, 2017

19.8K
A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.9K
Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
14:14

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Published on: August 12, 2018

9.4K

Area of Science:

  • Neurology
  • Neurosurgery
  • Pain Management

Background:

  • Chronic cluster headache (CCH) is a debilitating neurological condition.
  • Medically intractable CCH poses significant challenges for treatment.
  • Conventional therapies and occipital nerve stimulation may fail or be inaccessible.

Purpose of the Study:

  • To evaluate the efficacy and safety of ventral tegmental area deep brain stimulation (VTA-DBS) in patients with medically refractory CCH.
  • To assess the impact of VTA-DBS on headache frequency, severity, load, medication use, disability, and quality of life.

Main Methods:

  • An uncontrolled, open-label, prospective study involving 21 patients with medically refractory CCH.
  • Ipsilateral VTA-DBS was performed by a multidisciplinary team.
  • Outcomes included headache frequency, severity, load, medication use, disability, quality of life, and adverse events over a median follow-up of 18 months.

Main Results:

  • Significant improvements were observed: 60% reduction in headache frequency (p=0.007), 30% in headache severity (p=0.001), and 68% in headache load (p=0.002).
  • Total monthly triptan use decreased by 57%.
  • Improvements were noted in quality of life, disability, and mood scales, with manageable side effects.

Conclusions:

  • Ventral tegmental area deep brain stimulation (VTA-DBS) is a safe and effective therapeutic option for patients with refractory CCH.
  • VTA-DBS demonstrates significant potential in managing chronic cluster headaches that have not responded to conventional treatments.